Stock CMND CALEMINDER INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Caleminder Inc.

Equities

CMND

US12890A1051

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Caleminder Inc. -.--% -.--%
06-20 Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD MT
02-23 Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD
MT
Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder
MT
Clearmind Medicine Receives Patent Approval in China
MT
Clearmind Medicine, SciSpac Rising Wednesday after Filing US Patent Applications
MT
Pure Harvest Cannabis Producers Inc. and other buyers acquired a 25% stake in Caleminder Inc. for $0.05 million.
CI
Caleminder Inc. has completed an IPO in the amount of $0.05 million.
CI
Caleminder Inc. has filed an IPO in the amount of $0.05 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMND Stock
  4. News Caleminder Inc.
  5. Highlights